Can this COX-2 upstart ease the opioid burden after knee replacement surgery?
In the never-ending quest to get total knee arthroplasty (TKA) patients walking, flexing, and climbing stairs faster—with fewer opioids and less groaning—a new contender has entered the postoperative pain arena: Imrecoxib.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
